Global Glycogen Synthase Kinase 3 Beta Market Growth 2025-2031

October 2025 | 90 pages | ID: G98F37FEB861EN
LP Information

Abstracts

The global Glycogen Synthase Kinase 3 Beta market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

United States market for Glycogen Synthase Kinase 3 Beta is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Glycogen Synthase Kinase 3 Beta is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Glycogen Synthase Kinase 3 Beta is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Glycogen Synthase Kinase 3 Beta players cover Mitsubishi Tanabe Pharma Corp, Neurim Pharmaceuticals Ltd, Actuate Therapeutics Inc, DiaMedica Therapeutics Inc, Angelini Group, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the ?Glycogen Synthase Kinase 3 Beta Industry Forecast? looks at past sales and reviews total world Glycogen Synthase Kinase 3 Beta sales in 2024, providing a comprehensive analysis by region and market sector of projected Glycogen Synthase Kinase 3 Beta sales for 2025 through 2031. With Glycogen Synthase Kinase 3 Beta sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Glycogen Synthase Kinase 3 Beta industry.

This Insight Report provides a comprehensive analysis of the global Glycogen Synthase Kinase 3 Beta landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Glycogen Synthase Kinase 3 Beta portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Glycogen Synthase Kinase 3 Beta market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Glycogen Synthase Kinase 3 Beta and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Glycogen Synthase Kinase 3 Beta.

This report presents a comprehensive overview, market shares, and growth opportunities of Glycogen Synthase Kinase 3 Beta market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• AP-001
• AP-1
• DM-204
• Neu-120
• Others

Segmentation by Application:

• Musculoskeletal Disorder
• Lung Cancer
• Dyskinesia
• Menkes Disease
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Mitsubishi Tanabe Pharma Corp
• Neurim Pharmaceuticals Ltd
• Actuate Therapeutics Inc
• DiaMedica Therapeutics Inc
• Angelini Group
• Jeil Pharmaceutical Co Ltd
• AMO Pharma Ltd

Key Questions Addressed in this Report

What is the 10-year outlook for the global Glycogen Synthase Kinase 3 Beta market?
What factors are driving Glycogen Synthase Kinase 3 Beta market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Glycogen Synthase Kinase 3 Beta market opportunities vary by end market size?
How does Glycogen Synthase Kinase 3 Beta break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Glycogen Synthase Kinase 3 Beta Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Glycogen Synthase Kinase 3 Beta by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Glycogen Synthase Kinase 3 Beta by Country/Region, 2020, 2024 & 2031
2.2 Glycogen Synthase Kinase 3 Beta Segment by Type
  2.2.1 AP-001
  2.2.2 AP-1
  2.2.3 DM-204
  2.2.4 Neu-120
  2.2.5 Others
2.3 Glycogen Synthase Kinase 3 Beta Sales by Type
  2.3.1 Global Glycogen Synthase Kinase 3 Beta Sales Market Share by Type (2020-2025)
  2.3.2 Global Glycogen Synthase Kinase 3 Beta Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Glycogen Synthase Kinase 3 Beta Sale Price by Type (2020-2025)
2.4 Glycogen Synthase Kinase 3 Beta Segment by Application
  2.4.1 Musculoskeletal Disorder
  2.4.2 Lung Cancer
  2.4.3 Dyskinesia
  2.4.4 Menkes Disease
  2.4.5 Others
2.5 Glycogen Synthase Kinase 3 Beta Sales by Application
  2.5.1 Global Glycogen Synthase Kinase 3 Beta Sale Market Share by Application (2020-2025)
  2.5.2 Global Glycogen Synthase Kinase 3 Beta Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Glycogen Synthase Kinase 3 Beta Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Glycogen Synthase Kinase 3 Beta Breakdown Data by Company
  3.1.1 Global Glycogen Synthase Kinase 3 Beta Annual Sales by Company (2020-2025)
  3.1.2 Global Glycogen Synthase Kinase 3 Beta Sales Market Share by Company (2020-2025)
3.2 Global Glycogen Synthase Kinase 3 Beta Annual Revenue by Company (2020-2025)
  3.2.1 Global Glycogen Synthase Kinase 3 Beta Revenue by Company (2020-2025)
  3.2.2 Global Glycogen Synthase Kinase 3 Beta Revenue Market Share by Company (2020-2025)
3.3 Global Glycogen Synthase Kinase 3 Beta Sale Price by Company
3.4 Key Manufacturers Glycogen Synthase Kinase 3 Beta Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Glycogen Synthase Kinase 3 Beta Product Location Distribution
  3.4.2 Players Glycogen Synthase Kinase 3 Beta Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR GLYCOGEN SYNTHASE KINASE 3 BETA BY GEOGRAPHIC REGION

4.1 World Historic Glycogen Synthase Kinase 3 Beta Market Size by Geographic Region (2020-2025)
  4.1.1 Global Glycogen Synthase Kinase 3 Beta Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Glycogen Synthase Kinase 3 Beta Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Glycogen Synthase Kinase 3 Beta Market Size by Country/Region (2020-2025)
  4.2.1 Global Glycogen Synthase Kinase 3 Beta Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Glycogen Synthase Kinase 3 Beta Annual Revenue by Country/Region (2020-2025)
4.3 Americas Glycogen Synthase Kinase 3 Beta Sales Growth
4.4 APAC Glycogen Synthase Kinase 3 Beta Sales Growth
4.5 Europe Glycogen Synthase Kinase 3 Beta Sales Growth
4.6 Middle East & Africa Glycogen Synthase Kinase 3 Beta Sales Growth

5 AMERICAS

5.1 Americas Glycogen Synthase Kinase 3 Beta Sales by Country
  5.1.1 Americas Glycogen Synthase Kinase 3 Beta Sales by Country (2020-2025)
  5.1.2 Americas Glycogen Synthase Kinase 3 Beta Revenue by Country (2020-2025)
5.2 Americas Glycogen Synthase Kinase 3 Beta Sales by Type (2020-2025)
5.3 Americas Glycogen Synthase Kinase 3 Beta Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Glycogen Synthase Kinase 3 Beta Sales by Region
  6.1.1 APAC Glycogen Synthase Kinase 3 Beta Sales by Region (2020-2025)
  6.1.2 APAC Glycogen Synthase Kinase 3 Beta Revenue by Region (2020-2025)
6.2 APAC Glycogen Synthase Kinase 3 Beta Sales by Type (2020-2025)
6.3 APAC Glycogen Synthase Kinase 3 Beta Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Glycogen Synthase Kinase 3 Beta by Country
  7.1.1 Europe Glycogen Synthase Kinase 3 Beta Sales by Country (2020-2025)
  7.1.2 Europe Glycogen Synthase Kinase 3 Beta Revenue by Country (2020-2025)
7.2 Europe Glycogen Synthase Kinase 3 Beta Sales by Type (2020-2025)
7.3 Europe Glycogen Synthase Kinase 3 Beta Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Glycogen Synthase Kinase 3 Beta by Country
  8.1.1 Middle East & Africa Glycogen Synthase Kinase 3 Beta Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Glycogen Synthase Kinase 3 Beta Revenue by Country (2020-2025)
8.2 Middle East & Africa Glycogen Synthase Kinase 3 Beta Sales by Type (2020-2025)
8.3 Middle East & Africa Glycogen Synthase Kinase 3 Beta Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Glycogen Synthase Kinase 3 Beta
10.3 Manufacturing Process Analysis of Glycogen Synthase Kinase 3 Beta
10.4 Industry Chain Structure of Glycogen Synthase Kinase 3 Beta

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Glycogen Synthase Kinase 3 Beta Distributors
11.3 Glycogen Synthase Kinase 3 Beta Customer

12 WORLD FORECAST REVIEW FOR GLYCOGEN SYNTHASE KINASE 3 BETA BY GEOGRAPHIC REGION

12.1 Global Glycogen Synthase Kinase 3 Beta Market Size Forecast by Region
  12.1.1 Global Glycogen Synthase Kinase 3 Beta Forecast by Region (2026-2031)
  12.1.2 Global Glycogen Synthase Kinase 3 Beta Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Glycogen Synthase Kinase 3 Beta Forecast by Type (2026-2031)
12.7 Global Glycogen Synthase Kinase 3 Beta Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Mitsubishi Tanabe Pharma Corp
  13.1.1 Mitsubishi Tanabe Pharma Corp Company Information
  13.1.2 Mitsubishi Tanabe Pharma Corp Glycogen Synthase Kinase 3 Beta Product Portfolios and Specifications
  13.1.3 Mitsubishi Tanabe Pharma Corp Glycogen Synthase Kinase 3 Beta Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Mitsubishi Tanabe Pharma Corp Main Business Overview
  13.1.5 Mitsubishi Tanabe Pharma Corp Latest Developments
13.2 Neurim Pharmaceuticals Ltd
  13.2.1 Neurim Pharmaceuticals Ltd Company Information
  13.2.2 Neurim Pharmaceuticals Ltd Glycogen Synthase Kinase 3 Beta Product Portfolios and Specifications
  13.2.3 Neurim Pharmaceuticals Ltd Glycogen Synthase Kinase 3 Beta Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Neurim Pharmaceuticals Ltd Main Business Overview
  13.2.5 Neurim Pharmaceuticals Ltd Latest Developments
13.3 Actuate Therapeutics Inc
  13.3.1 Actuate Therapeutics Inc Company Information
  13.3.2 Actuate Therapeutics Inc Glycogen Synthase Kinase 3 Beta Product Portfolios and Specifications
  13.3.3 Actuate Therapeutics Inc Glycogen Synthase Kinase 3 Beta Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Actuate Therapeutics Inc Main Business Overview
  13.3.5 Actuate Therapeutics Inc Latest Developments
13.4 DiaMedica Therapeutics Inc
  13.4.1 DiaMedica Therapeutics Inc Company Information
  13.4.2 DiaMedica Therapeutics Inc Glycogen Synthase Kinase 3 Beta Product Portfolios and Specifications
  13.4.3 DiaMedica Therapeutics Inc Glycogen Synthase Kinase 3 Beta Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 DiaMedica Therapeutics Inc Main Business Overview
  13.4.5 DiaMedica Therapeutics Inc Latest Developments
13.5 Angelini Group
  13.5.1 Angelini Group Company Information
  13.5.2 Angelini Group Glycogen Synthase Kinase 3 Beta Product Portfolios and Specifications
  13.5.3 Angelini Group Glycogen Synthase Kinase 3 Beta Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 Angelini Group Main Business Overview
  13.5.5 Angelini Group Latest Developments
13.6 Jeil Pharmaceutical Co Ltd
  13.6.1 Jeil Pharmaceutical Co Ltd Company Information
  13.6.2 Jeil Pharmaceutical Co Ltd Glycogen Synthase Kinase 3 Beta Product Portfolios and Specifications
  13.6.3 Jeil Pharmaceutical Co Ltd Glycogen Synthase Kinase 3 Beta Sales, Revenue, Price and Gross Margin (2020-2025)
  13.6.4 Jeil Pharmaceutical Co Ltd Main Business Overview
  13.6.5 Jeil Pharmaceutical Co Ltd Latest Developments
13.7 AMO Pharma Ltd
  13.7.1 AMO Pharma Ltd Company Information
  13.7.2 AMO Pharma Ltd Glycogen Synthase Kinase 3 Beta Product Portfolios and Specifications
  13.7.3 AMO Pharma Ltd Glycogen Synthase Kinase 3 Beta Sales, Revenue, Price and Gross Margin (2020-2025)
  13.7.4 AMO Pharma Ltd Main Business Overview
  13.7.5 AMO Pharma Ltd Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Glycogen Synthase Kinase 3 Beta Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Glycogen Synthase Kinase 3 Beta Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of AP-001
Table 4. Major Players of AP-1
Table 5. Major Players of DM-204
Table 6. Major Players of Neu-120
Table 7. Major Players of Others
Table 8. Global Glycogen Synthase Kinase 3 Beta Sales by Type (2020-2025) & (K Pcs)
Table 9. Global Glycogen Synthase Kinase 3 Beta Sales Market Share by Type (2020-2025)
Table 10. Global Glycogen Synthase Kinase 3 Beta Revenue by Type (2020-2025) & ($ million)
Table 11. Global Glycogen Synthase Kinase 3 Beta Revenue Market Share by Type (2020-2025)
Table 12. Global Glycogen Synthase Kinase 3 Beta Sale Price by Type (2020-2025) & (USD/Pcs)
Table 13. Global Glycogen Synthase Kinase 3 Beta Sale by Application (2020-2025) & (K Pcs)
Table 14. Global Glycogen Synthase Kinase 3 Beta Sale Market Share by Application (2020-2025)
Table 15. Global Glycogen Synthase Kinase 3 Beta Revenue by Application (2020-2025) & ($ million)
Table 16. Global Glycogen Synthase Kinase 3 Beta Revenue Market Share by Application (2020-2025)
Table 17. Global Glycogen Synthase Kinase 3 Beta Sale Price by Application (2020-2025) & (USD/Pcs)
Table 18. Global Glycogen Synthase Kinase 3 Beta Sales by Company (2020-2025) & (K Pcs)
Table 19. Global Glycogen Synthase Kinase 3 Beta Sales Market Share by Company (2020-2025)
Table 20. Global Glycogen Synthase Kinase 3 Beta Revenue by Company (2020-2025) & ($ millions)
Table 21. Global Glycogen Synthase Kinase 3 Beta Revenue Market Share by Company (2020-2025)
Table 22. Global Glycogen Synthase Kinase 3 Beta Sale Price by Company (2020-2025) & (USD/Pcs)
Table 23. Key Manufacturers Glycogen Synthase Kinase 3 Beta Producing Area Distribution and Sales Area
Table 24. Players Glycogen Synthase Kinase 3 Beta Products Offered
Table 25. Glycogen Synthase Kinase 3 Beta Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global Glycogen Synthase Kinase 3 Beta Sales by Geographic Region (2020-2025) & (K Pcs)
Table 29. Global Glycogen Synthase Kinase 3 Beta Sales Market Share Geographic Region (2020-2025)
Table 30. Global Glycogen Synthase Kinase 3 Beta Revenue by Geographic Region (2020-2025) & ($ millions)
Table 31. Global Glycogen Synthase Kinase 3 Beta Revenue Market Share by Geographic Region (2020-2025)
Table 32. Global Glycogen Synthase Kinase 3 Beta Sales by Country/Region (2020-2025) & (K Pcs)
Table 33. Global Glycogen Synthase Kinase 3 Beta Sales Market Share by Country/Region (2020-2025)
Table 34. Global Glycogen Synthase Kinase 3 Beta Revenue by Country/Region (2020-2025) & ($ millions)
Table 35. Global Glycogen Synthase Kinase 3 Beta Revenue Market Share by Country/Region (2020-2025)
Table 36. Americas Glycogen Synthase Kinase 3 Beta Sales by Country (2020-2025) & (K Pcs)
Table 37. Americas Glycogen Synthase Kinase 3 Beta Sales Market Share by Country (2020-2025)
Table 38. Americas Glycogen Synthase Kinase 3 Beta Revenue by Country (2020-2025) & ($ millions)
Table 39. Americas Glycogen Synthase Kinase 3 Beta Sales by Type (2020-2025) & (K Pcs)
Table 40. Americas Glycogen Synthase Kinase 3 Beta Sales by Application (2020-2025) & (K Pcs)
Table 41. APAC Glycogen Synthase Kinase 3 Beta Sales by Region (2020-2025) & (K Pcs)
Table 42. APAC Glycogen Synthase Kinase 3 Beta Sales Market Share by Region (2020-2025)
Table 43. APAC Glycogen Synthase Kinase 3 Beta Revenue by Region (2020-2025) & ($ millions)
Table 44. APAC Glycogen Synthase Kinase 3 Beta Sales by Type (2020-2025) & (K Pcs)
Table 45. APAC Glycogen Synthase Kinase 3 Beta Sales by Application (2020-2025) & (K Pcs)
Table 46. Europe Glycogen Synthase Kinase 3 Beta Sales by Country (2020-2025) & (K Pcs)
Table 47. Europe Glycogen Synthase Kinase 3 Beta Revenue by Country (2020-2025) & ($ millions)
Table 48. Europe Glycogen Synthase Kinase 3 Beta Sales by Type (2020-2025) & (K Pcs)
Table 49. Europe Glycogen Synthase Kinase 3 Beta Sales by Application (2020-2025) & (K Pcs)
Table 50. Middle East & Africa Glycogen Synthase Kinase 3 Beta Sales by Country (2020-2025) & (K Pcs)
Table 51. Middle East & Africa Glycogen Synthase Kinase 3 Beta Revenue Market Share by Country (2020-2025)
Table 52. Middle East & Africa Glycogen Synthase Kinase 3 Beta Sales by Type (2020-2025) & (K Pcs)
Table 53. Middle East & Africa Glycogen Synthase Kinase 3 Beta Sales by Application (2020-2025) & (K Pcs)
Table 54. Key Market Drivers & Growth Opportunities of Glycogen Synthase Kinase 3 Beta
Table 55. Key Market Challenges & Risks of Glycogen Synthase Kinase 3 Beta
Table 56. Key Industry Trends of Glycogen Synthase Kinase 3 Beta
Table 57. Glycogen Synthase Kinase 3 Beta Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. Glycogen Synthase Kinase 3 Beta Distributors List
Table 60. Glycogen Synthase Kinase 3 Beta Customer List
Table 61. Global Glycogen Synthase Kinase 3 Beta Sales Forecast by Region (2026-2031) & (K Pcs)
Table 62. Global Glycogen Synthase Kinase 3 Beta Revenue Forecast by Region (2026-2031) & ($ millions)
Table 63. Americas Glycogen Synthase Kinase 3 Beta Sales Forecast by Country (2026-2031) & (K Pcs)
Table 64. Americas Glycogen Synthase Kinase 3 Beta Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 65. APAC Glycogen Synthase Kinase 3 Beta Sales Forecast by Region (2026-2031) & (K Pcs)
Table 66. APAC Glycogen Synthase Kinase 3 Beta Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 67. Europe Glycogen Synthase Kinase 3 Beta Sales Forecast by Country (2026-2031) & (K Pcs)
Table 68. Europe Glycogen Synthase Kinase 3 Beta Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Middle East & Africa Glycogen Synthase Kinase 3 Beta Sales Forecast by Country (2026-2031) & (K Pcs)
Table 70. Middle East & Africa Glycogen Synthase Kinase 3 Beta Revenue Forecast by Country (2026-2031) & ($ millions)
Table 71. Global Glycogen Synthase Kinase 3 Beta Sales Forecast by Type (2026-2031) & (K Pcs)
Table 72. Global Glycogen Synthase Kinase 3 Beta Revenue Forecast by Type (2026-2031) & ($ millions)
Table 73. Global Glycogen Synthase Kinase 3 Beta Sales Forecast by Application (2026-2031) & (K Pcs)
Table 74. Global Glycogen Synthase Kinase 3 Beta Revenue Forecast by Application (2026-2031) & ($ millions)
Table 75. Mitsubishi Tanabe Pharma Corp Basic Information, Glycogen Synthase Kinase 3 Beta Manufacturing Base, Sales Area and Its Competitors
Table 76. Mitsubishi Tanabe Pharma Corp Glycogen Synthase Kinase 3 Beta Product Portfolios and Specifications
Table 77. Mitsubishi Tanabe Pharma Corp Glycogen Synthase Kinase 3 Beta Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 78. Mitsubishi Tanabe Pharma Corp Main Business
Table 79. Mitsubishi Tanabe Pharma Corp Latest Developments
Table 80. Neurim Pharmaceuticals Ltd Basic Information, Glycogen Synthase Kinase 3 Beta Manufacturing Base, Sales Area and Its Competitors
Table 81. Neurim Pharmaceuticals Ltd Glycogen Synthase Kinase 3 Beta Product Portfolios and Specifications
Table 82. Neurim Pharmaceuticals Ltd Glycogen Synthase Kinase 3 Beta Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 83. Neurim Pharmaceuticals Ltd Main Business
Table 84. Neurim Pharmaceuticals Ltd Latest Developments
Table 85. Actuate Therapeutics Inc Basic Information, Glycogen Synthase Kinase 3 Beta Manufacturing Base, Sales Area and Its Competitors
Table 86. Actuate Therapeutics Inc Glycogen Synthase Kinase 3 Beta Product Portfolios and Specifications
Table 87. Actuate Therapeutics Inc Glycogen Synthase Kinase 3 Beta Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 88. Actuate Therapeutics Inc Main Business
Table 89. Actuate Therapeutics Inc Latest Developments
Table 90. DiaMedica Therapeutics Inc Basic Information, Glycogen Synthase Kinase 3 Beta Manufacturing Base, Sales Area and Its Competitors
Table 91. DiaMedica Therapeutics Inc Glycogen Synthase Kinase 3 Beta Product Portfolios and Specifications
Table 92. DiaMedica Therapeutics Inc Glycogen Synthase Kinase 3 Beta Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 93. DiaMedica Therapeutics Inc Main Business
Table 94. DiaMedica Therapeutics Inc Latest Developments
Table 95. Angelini Group Basic Information, Glycogen Synthase Kinase 3 Beta Manufacturing Base, Sales Area and Its Competitors
Table 96. Angelini Group Glycogen Synthase Kinase 3 Beta Product Portfolios and Specifications
Table 97. Angelini Group Glycogen Synthase Kinase 3 Beta Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 98. Angelini Group Main Business
Table 99. Angelini Group Latest Developments
Table 100. Jeil Pharmaceutical Co Ltd Basic Information, Glycogen Synthase Kinase 3 Beta Manufacturing Base, Sales Area and Its Competitors
Table 101. Jeil Pharmaceutical Co Ltd Glycogen Synthase Kinase 3 Beta Product Portfolios and Specifications
Table 102. Jeil Pharmaceutical Co Ltd Glycogen Synthase Kinase 3 Beta Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 103. Jeil Pharmaceutical Co Ltd Main Business
Table 104. Jeil Pharmaceutical Co Ltd Latest Developments
Table 105. AMO Pharma Ltd Basic Information, Glycogen Synthase Kinase 3 Beta Manufacturing Base, Sales Area and Its Competitors
Table 106. AMO Pharma Ltd Glycogen Synthase Kinase 3 Beta Product Portfolios and Specifications
Table 107. AMO Pharma Ltd Glycogen Synthase Kinase 3 Beta Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 108. AMO Pharma Ltd Main Business
Table 109. AMO Pharma Ltd Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Glycogen Synthase Kinase 3 Beta
Figure 2. Glycogen Synthase Kinase 3 Beta Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Glycogen Synthase Kinase 3 Beta Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global Glycogen Synthase Kinase 3 Beta Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Glycogen Synthase Kinase 3 Beta Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Glycogen Synthase Kinase 3 Beta Sales Market Share by Country/Region (2024)
Figure 10. Glycogen Synthase Kinase 3 Beta Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of AP-001
Figure 12. Product Picture of AP-1
Figure 13. Product Picture of DM-204
Figure 14. Product Picture of Neu-120
Figure 15. Product Picture of Others
Figure 16. Global Glycogen Synthase Kinase 3 Beta Sales Market Share by Type in 2025
Figure 17. Global Glycogen Synthase Kinase 3 Beta Revenue Market Share by Type (2020-2025)
Figure 18. Glycogen Synthase Kinase 3 Beta Consumed in Musculoskeletal Disorder
Figure 19. Global Glycogen Synthase Kinase 3 Beta Market: Musculoskeletal Disorder (2020-2025) & (K Pcs)
Figure 20. Glycogen Synthase Kinase 3 Beta Consumed in Lung Cancer
Figure 21. Global Glycogen Synthase Kinase 3 Beta Market: Lung Cancer (2020-2025) & (K Pcs)
Figure 22. Glycogen Synthase Kinase 3 Beta Consumed in Dyskinesia
Figure 23. Global Glycogen Synthase Kinase 3 Beta Market: Dyskinesia (2020-2025) & (K Pcs)
Figure 24. Glycogen Synthase Kinase 3 Beta Consumed in Menkes Disease
Figure 25. Global Glycogen Synthase Kinase 3 Beta Market: Menkes Disease (2020-2025) & (K Pcs)
Figure 26. Glycogen Synthase Kinase 3 Beta Consumed in Others
Figure 27. Global Glycogen Synthase Kinase 3 Beta Market: Others (2020-2025) & (K Pcs)
Figure 28. Global Glycogen Synthase Kinase 3 Beta Sale Market Share by Application (2024)
Figure 29. Global Glycogen Synthase Kinase 3 Beta Revenue Market Share by Application in 2025
Figure 30. Glycogen Synthase Kinase 3 Beta Sales by Company in 2025 (K Pcs)
Figure 31. Global Glycogen Synthase Kinase 3 Beta Sales Market Share by Company in 2025
Figure 32. Glycogen Synthase Kinase 3 Beta Revenue by Company in 2025 ($ millions)
Figure 33. Global Glycogen Synthase Kinase 3 Beta Revenue Market Share by Company in 2025
Figure 34. Global Glycogen Synthase Kinase 3 Beta Sales Market Share by Geographic Region (2020-2025)
Figure 35. Global Glycogen Synthase Kinase 3 Beta Revenue Market Share by Geographic Region in 2025
Figure 36. Americas Glycogen Synthase Kinase 3 Beta Sales 2020-2025 (K Pcs)
Figure 37. Americas Glycogen Synthase Kinase 3 Beta Revenue 2020-2025 ($ millions)
Figure 38. APAC Glycogen Synthase Kinase 3 Beta Sales 2020-2025 (K Pcs)
Figure 39. APAC Glycogen Synthase Kinase 3 Beta Revenue 2020-2025 ($ millions)
Figure 40. Europe Glycogen Synthase Kinase 3 Beta Sales 2020-2025 (K Pcs)
Figure 41. Europe Glycogen Synthase Kinase 3 Beta Revenue 2020-2025 ($ millions)
Figure 42. Middle East & Africa Glycogen Synthase Kinase 3 Beta Sales 2020-2025 (K Pcs)
Figure 43. Middle East & Africa Glycogen Synthase Kinase 3 Beta Revenue 2020-2025 ($ millions)
Figure 44. Americas Glycogen Synthase Kinase 3 Beta Sales Market Share by Country in 2025
Figure 45. Americas Glycogen Synthase Kinase 3 Beta Revenue Market Share by Country (2020-2025)
Figure 46. Americas Glycogen Synthase Kinase 3 Beta Sales Market Share by Type (2020-2025)
Figure 47. Americas Glycogen Synthase Kinase 3 Beta Sales Market Share by Application (2020-2025)
Figure 48. United States Glycogen Synthase Kinase 3 Beta Revenue Growth 2020-2025 ($ millions)
Figure 49. Canada Glycogen Synthase Kinase 3 Beta Revenue Growth 2020-2025 ($ millions)
Figure 50. Mexico Glycogen Synthase Kinase 3 Beta Revenue Growth 2020-2025 ($ millions)
Figure 51. Brazil Glycogen Synthase Kinase 3 Beta Revenue Growth 2020-2025 ($ millions)
Figure 52. APAC Glycogen Synthase Kinase 3 Beta Sales Market Share by Region in 2025
Figure 53. APAC Glycogen Synthase Kinase 3 Beta Revenue Market Share by Region (2020-2025)
Figure 54. APAC Glycogen Synthase Kinase 3 Beta Sales Market Share by Type (2020-2025)
Figure 55. APAC Glycogen Synthase Kinase 3 Beta Sales Market Share by Application (2020-2025)
Figure 56. China Glycogen Synthase Kinase 3 Beta Revenue Growth 2020-2025 ($ millions)
Figure 57. Japan Glycogen Synthase Kinase 3 Beta Revenue Growth 2020-2025 ($ millions)
Figure 58. South Korea Glycogen Synthase Kinase 3 Beta Revenue Growth 2020-2025 ($ millions)
Figure 59. Southeast Asia Glycogen Synthase Kinase 3 Beta Revenue Growth 2020-2025 ($ millions)
Figure 60. India Glycogen Synthase Kinase 3 Beta Revenue Growth 2020-2025 ($ millions)
Figure 61. Australia Glycogen Synthase Kinase 3 Beta Revenue Growth 2020-2025 ($ millions)
Figure 62. China Taiwan Glycogen Synthase Kinase 3 Beta Revenue Growth 2020-2025 ($ millions)
Figure 63. Europe Glycogen Synthase Kinase 3 Beta Sales Market Share by Country in 2025
Figure 64. Europe Glycogen Synthase Kinase 3 Beta Revenue Market Share by Country (2020-2025)
Figure 65. Europe Glycogen Synthase Kinase 3 Beta Sales Market Share by Type (2020-2025)
Figure 66. Europe Glycogen Synthase Kinase 3 Beta Sales Market Share by Application (2020-2025)
Figure 67. Germany Glycogen Synthase Kinase 3 Beta Revenue Growth 2020-2025 ($ millions)
Figure 68. France Glycogen Synthase Kinase 3 Beta Revenue Growth 2020-2025 ($ millions)
Figure 69. UK Glycogen Synthase Kinase 3 Beta Revenue Growth 2020-2025 ($ millions)
Figure 70. Italy Glycogen Synthase Kinase 3 Beta Revenue Growth 2020-2025 ($ millions)
Figure 71. Russia Glycogen Synthase Kinase 3 Beta Revenue Growth 2020-2025 ($ millions)
Figure 72. Middle East & Africa Glycogen Synthase Kinase 3 Beta Sales Market Share by Country (2020-2025)
Figure 73. Middle East & Africa Glycogen Synthase Kinase 3 Beta Sales Market Share by Type (2020-2025)
Figure 74. Middle East & Africa Glycogen Synthase Kinase 3 Beta Sales Market Share by Application (2020-2025)
Figure 75. Egypt Glycogen Synthase Kinase 3 Beta Revenue Growth 2020-2025 ($ millions)
Figure 76. South Africa Glycogen Synthase Kinase 3 Beta Revenue Growth 2020-2025 ($ millions)
Figure 77. Israel Glycogen Synthase Kinase 3 Beta Revenue Growth 2020-2025 ($ millions)
Figure 78. Turkey Glycogen Synthase Kinase 3 Beta Revenue Growth 2020-2025 ($ millions)
Figure 79. GCC Countries Glycogen Synthase Kinase 3 Beta Revenue Growth 2020-2025 ($ millions)
Figure 80. Manufacturing Cost Structure Analysis of Glycogen Synthase Kinase 3 Beta in 2025
Figure 81. Manufacturing Process Analysis of Glycogen Synthase Kinase 3 Beta
Figure 82. Industry Chain Structure of Glycogen Synthase Kinase 3 Beta
Figure 83. Channels of Distribution
Figure 84. Global Glycogen Synthase Kinase 3 Beta Sales Market Forecast by Region (2026-2031)
Figure 85. Global Glycogen Synthase Kinase 3 Beta Revenue Market Share Forecast by Region (2026-2031)
Figure 86. Global Glycogen Synthase Kinase 3 Beta Sales Market Share Forecast by Type (2026-2031)
Figure 87. Global Glycogen Synthase Kinase 3 Beta Revenue Market Share Forecast by Type (2026-2031)
Figure 88. Global Glycogen Synthase Kinase 3 Beta Sales Market Share Forecast by Application (2026-2031)
Figure 89. Global Glycogen Synthase Kinase 3 Beta Revenue Market Share Forecast by Application (2026-2031)